Skip to main content

Advertisement

SpringerLink
Log in

Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Chronic kidney disease (CKD) is not only a common comorbidity among patients presenting with acute coronary syndrome (ACS), it is also an entity that portends worse short- and long-term prognosis. Differences in the pathophysiology of arterial atherosclerosis and calcification, chronic inflammation, platelet reactivity, and thrombogenicity in patients with and without CKD underpin the increased vulnerability of CKD patients with ACS to subsequent ischemic and bleeding complications. These differences, as well as the frequent exclusion of CKD patients from randomized control trials, create uncertainty regarding the benefit of invasive treatment for ACS in patients with CKD. The limited evidence from randomized trials suggests a benefit with invasive treatment in CKD patients with ACS. However, some data from registry studies suggest no benefit or even harm with invasive therapy. Thus, the optimal management of ACS in patients with CKD, in particular end-stage CKD, remains uncertain. In this article we review the characteristics of coronary artery disease in patients with CKD, the available evidence pertaining to the outcomes of CKD patients with ACS with invasive versus conservative therapy, and potential areas for reducing complications of invasive therapy in this high-risk subset of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. K/doqi clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266

    Google Scholar 

  2. Us renal data system, usrds 2011 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the united states, national institutes of health, national institute of diabetes and digestive kidney disease, bethesda, md, 2011.

  3. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD. Use of evidence-based therapies in short-term outcomes of st-segment elevation myocardial infarction and non-st-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation. 2010;121:357–65.

    Article  PubMed  CAS  Google Scholar 

  4. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, Gulba D, Esteban J, Gore JM, Johnson J, Gurfinkel EP. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: Findings from the global registry of acute coronary events (grace). Heart. 2003;89:1003–8.

    Article  PubMed  CAS  Google Scholar 

  5. Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: An acuity (acute catheterization and urgent intervention triage strategy) substudy. JACC Cardiovasc Interv. 2009;2:748–57.

    Article  PubMed  Google Scholar 

  6. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The dallas heart study. J Am Soc Nephrol. 2005;16:507–13.

    Article  PubMed  Google Scholar 

  7. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyohara Y, Sueishi K. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from japanese elders: The hisayama study. Am J Kidney Dis. 2010;55:21–30.

    Article  PubMed  Google Scholar 

  8. Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, Mintz GS, Cristea E, Fahy M, Xu K, Lansky AJ, Wennerblom B, Mathey DG, Templin B, Zhang Z, Serruys PW, Mehran R. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5:S53–61.

    Article  PubMed  Google Scholar 

  9. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113–9.

    Article  PubMed  Google Scholar 

  10. Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabate M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, Macaya C, Fernandez-Ortiz A. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol. 2010;55:1139–46.

    Article  PubMed  CAS  Google Scholar 

  11. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70:2021–30.

    PubMed  CAS  Google Scholar 

  12. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. Jama. 2006;296:1377–84.

    Article  PubMed  CAS  Google Scholar 

  13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70.

    PubMed  CAS  Google Scholar 

  14. Geisler T, Grass D, Bigalke B, Stellos K, Drosch T, Dietz K, Herdeg C, Gawaz M. The residual platelet aggregation after deployment of intracoronary stent (predict) score. J Thromb Haemost. 2008;6:54–61.

    Article  PubMed  CAS  Google Scholar 

  15. Baber U, Zafar MU, Uribarri J, Murphy B, Khan A, Akter F, Bander J, Muntner P, Kovacic JC, Yu J, Theodoropoulos K, Mehran R, Dangas G, Kini A, Sharma S, Fuster V, Badimon J. Physiologic impact of chronic kidney disease on whole blood clot kinetics and strength. J Am Coll Cardiol. 2012;59:E2096.

    Article  Google Scholar 

  16. Chirumamilla AP, Maehara A, Mintz G, Mehran R, Kanwal S, Weisz G, Hassanin A, Hakim DA, Guo N, Baber U, Pyo R, Moses JW, Fahy M, Kovacic JC, Dangas GD. High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification. JACC Cardiovasc Imaging. 2012;In Press

  17. Brar SS, ten Berg J, Marcucci R, Price MJ, Valgimigli M, Kim HS, Patti G, Breet NJ, DiSciascio G, Cuisset T, Dangas G. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011;58:1945–54.

    Article  PubMed  Google Scholar 

  18. Dumaine R, Collet JP, Tanguy ML, Mansencal N, Dubois-Rande JL, Henry P, Steg PG, Michel PL, Allouch P, Cohen A, Colin P, Durand E, Montalescot G. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the prospective multicenter sycomore study). Am J Cardiol. 2004;94:1543–7.

    Article  PubMed  Google Scholar 

  19. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of glomerular filtration rate on presentation with subsequent mortality in non-st-segment elevation acute coronary syndrome; observations in 13,307 patients in five timi trials. Eur Heart J. 2004;25:1998–2005.

    Article  PubMed  Google Scholar 

  20. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes Jr DR. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974–80.

    Article  PubMed  Google Scholar 

  21. • Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, Ferreira-Gonzalez I, Benderly M, Guetta V, Behar S, Marrugat J. Relation between renal function and outcomes in patients with non-st-segment elevation acute coronary syndrome: Real-world data from the european public health outcome research and indicators collection project. Arch Intern Med. 2010;170:888–95. This is a large registry study comparing survival among patients who received invasive versus conservative treatment for NSTEACS according to the presence of mild, moderate, or severe CKD.

    Article  PubMed  Google Scholar 

  22. Baber U, Kini AS, Sharma SK, Kim MC, Farkouh ME, Muntner P. Thrombolysis in myocardial infarction (timi) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. Am J Cardiol. 2009;103:1513–7.

    Article  PubMed  Google Scholar 

  23. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith Jr SC, Pollack Jr CV, Gibler WB, Ohman EM. Utilization of early invasive management strategies for high-risk patients with non-st-segment elevation acute coronary syndromes: Results from the crusade quality improvement initiative. Jama. 2004;292:2096–104.

    Article  PubMed  CAS  Google Scholar 

  24. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769–75.

    Article  PubMed  Google Scholar 

  25. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.

    PubMed  Google Scholar 

  26. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (the tactics-timi 18 trial). Am J Cardiol. 2002;90:1246–9.

    Article  PubMed  Google Scholar 

  27. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the replace-2 (randomized evaluation of pci linking angiomax to reduced clinical events), acuity (acute catheterization and urgent intervention triage strategy), and horizons-ami (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654–64.

    Article  PubMed  Google Scholar 

  28. Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, Copetti M, Graziano G, Tognoni G, Jardine M, Webster A, Nicolucci A, Zoungas S, Strippoli GF. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: A systematic review and meta-analysis. Ann Intern Med. 2012;156:445–59.

    PubMed  Google Scholar 

  29. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes Jr DR. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.

    Article  PubMed  Google Scholar 

  30. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005;64:442–8.

    Article  PubMed  Google Scholar 

  31. James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P, Pannu N, Manns BJ, Klarenbach SW, Hemmelgarn BR. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation. 2011;123:409–16.

    Article  PubMed  Google Scholar 

  32. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King 3rd SB, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the acuity trial. J Am Coll Cardiol. 2007;49:1362–8.

    Article  PubMed  Google Scholar 

  33. Chew DP, Bhatt DL, Kimball W, Henry TD, Berger P, McCullough PA, Feit F, Bittl JA, Lincoff AM. Bivalirudin provides increasing benefit with decreasing renal function: A meta-analysis of randomized trials. Am J Cardiol. 2003;92:919–23.

    Article  PubMed  CAS  Google Scholar 

  34. Chew DP, Lincoff AM, Gurm H, Wolski K, Cohen DJ, Henry T, Feit F, Topol EJ. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the replace-2 trial). Am J Cardiol. 2005;95:581–5.

    Article  PubMed  CAS  Google Scholar 

  35. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation. 2004;110:1890–5.

    Article  PubMed  Google Scholar 

  36. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol. 2003;92:509–14.

    Article  PubMed  Google Scholar 

  37. • Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, Wallentin L, Jernberg T. Influence of renal function on the effects of early revascularization in non-st-elevation myocardial infarction: data from the swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (swedeheart). Circulation. 2009;120:851–8. This is a large registry that examined outcomes of patients with non-ST elevation MI according to renal function and treatment with PCI, CABG, or medical therapy.

    Article  PubMed  CAS  Google Scholar 

  38. •• Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK. Early angiography in patients with chronic kidney disease: A collaborative systematic review. Clin J Am Soc Nephrol. 2009;4:1032–43. This is a meta-analysis comparing routine early invasive versus conversative strategy (angiography for ongoing symptoms or failed stress test) among patients with and without CKD.

    Article  PubMed  Google Scholar 

  39. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey Jr DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK. 2011 accf/aha focused update of the guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction (updating the 2007 guideline): A report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2011;123:2022–60.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Mount Sinai Medical Center, New York, NY, USA

    Jennifer Yu, Ziad Sergie & Usman Baber

  2. Prince of Wales Hospital, Barker Street, Randwick, NSW, 2031, Australia

    Jennifer Yu & Sze-Yuan Ooi

  3. One Gustave L. Levy Place, Box 1030, New York, NY, 10029, USA

    Jennifer Yu, Ziad Sergie & Usman Baber

Authors
  1. Jennifer Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sze-Yuan Ooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ziad Sergie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Usman Baber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, J., Ooi, SY., Sergie, Z. et al. Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data. Curr Cardiol Rep 14, 521–527 (2012). https://doi.org/10.1007/s11886-012-0284-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-012-0284-8

Keywords

Search

Navigation